Home
Conditions
Neoplastic Processes

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

NCT02364557

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Breast Diseases, +17 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

CTCA at Western Regional Medical Center Goodyear, Arizona, United States

Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 162 locations

View Trial Details

Completed

Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.

NCT07692607

Conditions: Autologous Hematopoietic Stem Cell Transplant, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: The Catholic University of Korea Seoul St.Mary's Hospital Seoul, South Korea

View Trial Details

Completed

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

NCT05415475

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +29 more
Locations: Shandong Second Provincial General Hospital Jinan, Shandong, China

View Trial Details

Completed

Does Anesthesia Technique Impact on the Long-term Outcome 5 and 10 Years After the First Intervention in Primary Breast Cancer Surgery? A Follow-up Analysis.

NCT07689253

Conditions: Breast Cancer Females, Circulating Tumor Cells.Breast, Follow Up Analysis, +6 more
Locations: University Hospital Zurich, Institute of Anesthesiology and Perioperative Medicine Zurich, Canton of Zurich, Switzerland

View Trial Details

Completed

Natural Killer Cells and Bortezomib to Treat Cancer

NCT00720785

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Bronchial Neoplasms, +40 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

NCT02710253

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +8 more
Locations: MD Anderson in The Woodlands Conroe, Texas, United States

M D Anderson Cancer Center Houston, Texas, United States

MD Anderson West Houston Houston, Texas, United States

MD Anderson League City League City, Texas, United States

View Trial Details

Completed

Ultrasound-Guided Hook-Wire Localization for Excision of Non-palpable Cervical Lesions Suspicious for Metastasis

NCT07672912

Conditions: Head and Neck Neoplasms, Lymphatic Metastasis, Neoplasm Metastasis, +6 more
Locations: Karolinska University Hospital Stockholm, Stockholm County, Sweden

View Trial Details

Completed

Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

NCT04205812

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: Pacific Cancer Medical Center Anaheim, California, United States

Innovative Clinical Research Institute Whittier, California, United States

Reading Hospital and Medical Center Reading, Pennsylvania, United States

Fundacao Pio Xii Hospital de Cancer de Barretos Barretos, Brazil

View all 140 locations

View Trial Details

Completed

Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)

NCT03391973

Conditions: Carcinoma of Unknown Primary, Neoplasm Metastasis, Neoplasms, +4 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada

View Trial Details

Completed

Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer

NCT00317720

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Neoplastic Processes

Neoplastic Processes trial results

Related conditions